Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC LY2606368 1234015-52-1 25mg
SDP

Supplier:  Apexbio Technology LLC B108825

Encompass_Preferred

LY2606368 (CAS 1234015-52-1) is a selective ATP-competitive inhibitor of checkpoint kinase 1 (CHK1) a serine/threonine kinase integral to the DNA damage response pathway In SW1990 pancreatic cancer cells LY2606368 exhibits potent inhibition of cell proliferation with an IC50 value of 1 5 nM The compound suppresses CHK1 autophosphorylation and induces phosphorylation of H2AX reflective of DNA damage signaling In vivo studies show that LY2606368 reduces tumor growth in SW1990 xenograft and SKOV3 orthotopic models and lowers tumor metastasis rates Due to low oral bioavailability administration is intravenous LY2606368 is under clinical investigation as an anticancer agent

Catalog No. 50-000-89601


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.